Published in Gastrointest Endosc on May 01, 2005
Endoluminal fundoplication by a transoral device for the treatment of GERD: A feasibility study. Surg Endosc (2007) 1.19
Endoscopic full-thickness plication for the treatment of GERD: long-term multicenter results. Surg Endosc (2006) 0.99
Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease using multiple Plicator implants: 12-month multicenter study results. Surg Endosc (2009) 0.96
Endoluminal and transluminal surgery: current status and future possibilities. Surg Endosc (2006) 0.94
Endotherapy for GERD: angels and demons. Gastrointest Endosc (2005) 0.83
Endoscopic treatment of refractory gastroesohageal reflux disease. Clin Endosc (2013) 0.81
Endoscopic full-thickness plication for the treatment of GERD: Five-year long-term multicenter results. Surg Endosc (2007) 0.80
Advances in the evaluation and management of esophageal disease of systemic sclerosis. Curr Rheumatol Rep (2015) 0.77
Visceral artery embolization after endoscopic injection of Enteryx for gastroesophageal reflux disease. J Radiol Case Rep (2014) 0.75
Endoscopic treatment of gastro-oesophageal reflux disease. Acta Otorhinolaryngol Ital (2006) 0.75
Thinking outside the box: autotransplantation into GI sphincters. Gastrointest Endosc (2009) 0.75
Endoscopic treatment for gastroesophageal reflux disease: should you learn the techniques? Can J Gastroenterol (2007) 0.75
Endoscopic therapy for gastroesophageal reflux disease--new data. Rev Gastroenterol Disord (2005) 0.75
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63
Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med (2009) 6.31
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med (2012) 4.51
Endoscopic treatment for Zenker's diverticulum: long-term results (with video). Gastrointest Endosc (2013) 4.30
Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol (2006) 3.57
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data. Hepatology (2014) 3.30
Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology (2004) 3.25
The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology (2009) 2.92
Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg (2004) 2.82
Endoscopic drainage of pancreatic-fluid collections in 116 patients: a comparison of etiologies, drainage techniques, and outcomes. Gastrointest Endosc (2006) 2.79
Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center. Gastrointest Endosc (2007) 2.77
Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol (2006) 2.70
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial. Am J Gastroenterol (2003) 2.63
International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg (2015) 2.61
Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc (2010) 2.57
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila) (2009) 2.46
Large-diameter biliary orifice balloon dilation to aid in endoscopic bile duct stone removal: a multicenter series. Gastrointest Endosc (2008) 2.44
Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg (2003) 2.36
AGA Institute review of endoscopic sedation. Gastroenterology (2007) 2.35
Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc (2011) 2.30
Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol (2009) 2.28
Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell (2013) 2.23
Pancreatic-fluid collections: a randomized controlled trial regarding stent removal after endoscopic transmural drainage. Gastrointest Endosc (2007) 2.17
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol (2008) 2.16
Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison. Am J Gastroenterol (2006) 2.07
Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg (2008) 2.06
A case series of symptomatic intraluminal duodenal duplication cysts: presentation, endoscopic therapy, and long-term outcome (with video). Gastrointest Endosc (2008) 2.06
Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol (2002) 2.05
Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology (2004) 2.02
EUS-guided pancreatogastrostomy and pancreatobulbostomy for the treatment of pain in patients with pancreatic ductal dilatation inaccessible for transpapillary endoscopic therapy. Gastrointest Endosc (2007) 2.01
CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology (2005) 1.88
Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc (2009) 1.85
Endoscopic removal of dysfunctioning bands or rings after restrictive bariatric procedures. Gastrointest Endosc (2009) 1.84
Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Am J Gastroenterol (2003) 1.84
Individual and practice differences among physicians who perform ERCP at varying frequency: a national survey. Gastrointest Endosc (2011) 1.82
ERCP via gastrostomy vs. double balloon enteroscopy in patients with prior bariatric Roux-en-Y gastric bypass surgery. Surg Endosc (2013) 1.81
Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc (2006) 1.79
Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results. Gastrointest Endosc (2007) 1.78
Endoscopic treatment of external pancreatic fistulas: when draining the main pancreatic duct is not enough. Am J Gastroenterol (2007) 1.74
Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev Vaccines (2003) 1.74
Effects of droperidol on the pancreatic and biliary sphincters. Gastrointest Endosc (2003) 1.74
Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc (2004) 1.72
Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc (2002) 1.70
Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study. Gastrointest Endosc (2012) 1.70
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol (2005) 1.70
Endoscopic Doppler optical coherence tomography in the human GI tract: initial experience. Gastrointest Endosc (2005) 1.68
Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology (2006) 1.68
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Gastroenterology (2012) 1.67
Clinical impact of biliary drainage and jaundice resolution in patients with obstructive metastases at the hilum. Am J Gastroenterol (2003) 1.67
Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol (2002) 1.66
Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram. Gastrointest Endosc (2003) 1.65
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma. Clin Cancer Res (2009) 1.62
Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol (2012) 1.61
Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest Endosc (2004) 1.56
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology (2005) 1.55
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointest Endosc (2005) 1.54
Wireless capsule endoscopy for obscure gastrointestinal bleeding: a single-centre, one-year experience. Can J Gastroenterol (2004) 1.53
Acute pancreatitis after removal of retained prophylactic pancreatic stents. Gastrointest Endosc (2011) 1.51
Clinical concerns of alendronate use. J Oral Maxillofac Surg (2007) 1.51
EUS-guided pancreaticogastrostomy. Gastrointest Endosc (2002) 1.50
Endoscopic cystenterostomy of nonbulging pancreatic fluid collections. Gastrointest Endosc (2002) 1.50
Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology (2011) 1.49
Endoscopic snare papillectomy for tumors of the duodenal papillae. Gastrointest Endosc (2004) 1.49
Esophageal function testing with combined multichannel intraluminal impedance and manometry: multicenter study in healthy volunteers. Clin Gastroenterol Hepatol (2003) 1.48
Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg (2006) 1.47
Propofol for endoscopic sedation: A protocol for safe and effective administration by the gastroenterologist. Gastrointest Endosc (2003) 1.47
Eosinophilic esophagitis with severe GERD. Am J Gastroenterol (2009) 1.47
Reduced medication dependency and improved symptoms and quality of life 12 months after enteryx implantation for gastroesophageal reflux. J Clin Gastroenterol (2005) 1.46
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. J Am Coll Cardiol (2009) 1.44
A simple tissue-handling technique performed in the endoscopy suite improves histologic section quality and diagnostic accuracy for serrated polyps. Endoscopy (2013) 1.43
Self-expandable metal stents for the treatment of benign upper GI leaks and perforations. Gastrointest Endosc (2011) 1.42
Atypical variants of classic achalasia are common and currently under-recognized: a study of prevalence and clinical features. J Am Coll Surg (2011) 1.41
Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells. Ann Surg (2012) 1.40
ERCP findings in idiopathic pancreatitis: patients who are cystic fibrosis gene positive and negative. Gastrointest Endosc (2006) 1.40
Microsatellite polymorphism in the heme oxygenase-1 gene promoter is not associated with alcoholic liver disease severity. Hepatology (2013) 1.39
The LINX® reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc (2012) 1.37
Physiologic basis for the treatment of epiphrenic diverticulum. Ann Surg (2002) 1.37
Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg (2004) 1.37
Therapeutic EUS-assisted endoscopic retrograde pancreatography after failed pancreatic duct cannulation at ERCP. Gastrointest Endosc (2010) 1.36
Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg (2010) 1.36
Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care. Am J Gastroenterol (2008) 1.35
Structure-activity relationship of synthetic toll-like receptor 4 agonists. J Biol Chem (2003) 1.35
Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol (2002) 1.33
Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother (2005) 1.31